Литература
1. Podkowińska A., Formanowicz D. Chronic kidney disease as oxidative stress-and inflammatory-mediated cardiovascular disease // Antioxidants (Basel). 2020. Vol. 9, N. 8. P. 752. DOI: https://doi.org/10.3390/antiox9080752
2. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 // Lancet. 2020. Vol. 395. P. 709–733. DOI: https://doi.org/10.1016/S0140-6736(20)30045-3
3. Tinti F., Lai S., Noce A., Rotondi S., Marrone G., Mazzaferro S. et al. Chronic kidney disease as a systemic inflammatory syndrome: update on mechanisms involved and potential treatment // Life (Basel). 2021. Vol. 11, N 5. P. 419. DOI: https://doi.org/10.3390/life11050419
4. Wang G., Ouyang J., Li S., Wang H., Lian B., Liu Z. et al. The analysis of risk factors for diabetic nephropathy progression and the construction of a prognostic database for chronic kidney diseases // J. Transl. Med. 2019. Vol. 17. P. 264. DOI: https://doi.org/10.1186/s12967-019-2016-y
5. Jankowska M., Rutkowski B., Dębska-Ślizień A. Vitamins and microelement bioavailability in different stages of chronic kidney disease // Nutrients. 2017. Vol. 9, N 3. P. 282. DOI: https://doi.org/10.3390/nu9030282
6. van de Wal-Visscher E.R., Kooman J.P., van der Sande F.M. Magnesium in chronic kidney disease: should we care? // Blood Purif. 2018. Vol. 45, N 1–3. P. 173–178. DOI: https://doi.org/10.1159/000485212
7. Van Kempen T.A., Deixler E. SARS-CoV-2: influence of phosphate and magnesium, moderated by vitamin D, on energy (ATP) metabolism and on severity of COVID-19 // Am. J. Physiol. Endocrinol. Metab. 2021. Vol. 320, N 1. P. E2–E6. DOI: https://doi.org/10.1152/ajpendo.00474.2020
8. Tanaka K., Ao M., Kuwabara A. Insufficiency of B vitamins with its possible clinical implications // J. Clin. Biochem. Nutr. 2020. Vol. 67, N 1. P. 19–25. DOI: https://doi.org/10.3164/jcbn.20-56
9. Adaikalakoteswari A.A., Rabbani N.A., Waspadji S.B., Tjokroprawiro A.C., Kariadi S.H.D., Adam J.M.F.E. et al. Disturbance of B-vitamin status in people with type 2 diabetes in Indonesia – link to renal status, glycemic control and vascular inflammation // Diabetes Res. Clin. Pract. 2012. Vol. 95, N 3. P. 415–424. DOI: https://doi.org/10.1016/j.diabres.2011.10.042
10. Iwakawa H., Nakamura Y., Fukui T., Fukuwatar T., Ugi S., Maegawa H. et al. Concentrations of water-soluble vitamins in blood and urinary excretion in patients with diabetes mellitus // Nutr. Metab. Insights. 2016. Vol. 9. P. 85–92. DOI: https://doi.org/10.4137/NMI.S40595
11. Anwar A., Azmi M.A., Siddiqui J.A., Panhwar G., Shaikh F., Ariff M. Thiamine level in type I and type II diabetes mellitus patients: a comparative study focusing on hematological and biochemical evaluations // Cureus. 2020. Vol. 12, N 5. P. e8027. DOI: https://doi.org/10.7759/cureus.8027
12. Nix W.A., Zirwes R., Bangert V., Kaiser R.P., Schilling M., Hostalek U. et al. Vitamin B status in patients with type 2 diabetes mellitus with and without incipient nephropathy // Diabetes Res. Clin. Pract. 2015. Vol. 107, N 1. P. 157–165. DOI: https://doi.org/10.1016/j.diabres.2014.09.058
13. Valdés-Ramos R., Guadarrama-López A.L., Martínez-Carrillo B.E., Benítez-Arciniega A.D. Vitamins and type 2 diabetes mellitus // Endocr. Metab. Immune Disord. Drug Targets. 2015. Vol. 15, N 1. P. 54–63. DOI: https://doi.org/10.2174/1871530314666141111103217
14. Gavrilov V., Harman-Boehm I., Amichay D., Tessler G., Shuster T., Friger M. et al. Kidney function and retinol status in type 2 diabetes mellitus patients // Acta Diabetol. 2012. Vol. 49, N 2. P. 137–143. DOI: https://doi.org/10.1007/s00592-011-0303-z
15. Новикова М.С., Руденко Т.Е., Котяшкова О.М., Анциферов М.Б. Минерально-костные нарушения у пациентов с сахарным диабетом и хронической болезнью почек // Эффективная фармакотерапия. 2013. № 46. С. 46–52.
16. Jean G., Souberbielle J.C., Chazot C. Vitamin D in chronic kidney disease and dialysis patients // Nutrients. 2017. Vol. 9, N 4. P. 328. DOI: https://doi.org/10.3390/nu9040328
17. de Bragança A.C., Canale D., Gonçalves J.G., Shimizu M.H.M., Seguro A.C., Volpini R.A. Vitamin D deficiency aggravates the renal features of moderate chronic kidney disease in 5/6 nephrectomized rats // Front. Med. (Lausanne). 2018. Vol. 5. P. 282. DOI: https://doi.org/10.3389/fmed.2018.00282
18. Delrue C., Speeckaert R., Delanghe J.R., Speeckaert M.M. The role of vitamin D in diabetic nephropathy: a translational approach // Int. J. Mol. Sci. 2022. Vol. 23, N 2. P. 807. DOI: https://doi.org/10.3390/ijms23020807
19. Felício J.S., de Rider Britto H.A., Cortez P.C., de Souza Resende F., de Lemos M.N., De Moraes L.V. et al. Association between 25 (OH) vitamin D, HbA1c and albuminuria in diabetes mellitus: data from a population-based study (VIDAMAZON) // Front. Endocrinol. (Lausanne). 2021. Vol. 12. Article ID 723502. DOI: https://doi.org/10.3389/fendo.2021.723502
20. Gembill G., Cernaro V., Salvo A., Siligato R., Laudani A., Buemi M. et al. Role of vitamin D status in diabetic patients with renal disease // Medicina (Kaunas). 2019. Vol. 55, N 6. P. 273. DOI: https://doi.org/10.3390/medicina55060273
21. Демидова Т.Ю., Лобанова К.Г., Переходов С.Н., Анциферов М.Б., Ойноткинова О.Ш. Клинико-лабораторная характеристика пациентов с COVID-19 и сопутствующим сахарным диабетом 2 типа // Кардиоваскулярная терапия и профилактика. 2021. Т. 20, № 1. С. 47–52. DOI: https://doi.org/10.15829/1728-8800-2021-2750
22. Gonçalves S.E.A.B., Gonçalves T.J.M., Guarnieri A., Risegato R.C., Guimarães M.P., de Freitas D.C. Association between thiamine deficiency and hyperlactatemia among critically ill patients with diabetes infected by SARS-CoV-2 // J. Diabetes. 2021. Vol. 13, N 5. DOI: https://doi.org/10.1111/1753-0407.13156
23. Figueroa-Pizano M.D., Campa-Mada A.C., Carvajal-Millan E., Martinez-Robinson K.G., Chu A.R. The underlying mechanisms for severe COVID-19 progression in people with diabetes mellitus: a critical review // AIMS Public Health. 2021. Vol. 8, N 4. Р. 720–742. DOI: https://doi.org/10.3934/publichealth.2021057
24. Якушина Л.М., Бекетова Н.А., Бендер Е.Д., Харитончик Л.А. Использование методов ВЭЖХ для определения витаминов в биологических жидкостях и пищевых продуктах // Вопросы питания. 1993. № 1. С. 43–48.
25. Kodentsova V., Vrzhesinskaya O., Spirichev V. Fluorometric riboflavin titration in plasma by riboflavin binding apoprotein as a method for vitamin B2 status assessment // Ann. Nutr. Metab. 1995. Vol. 39. P. 355–360. DOI: https://doi.org/10.1159/000177885
26. Коденцова В.М., Харитончик Л.А., Вржесинская О.А., Переверзева О.Г., Блажеевич Н.В., Спиричев В.Б. Уточнение критериев обеспеченности организма витамином С // Вопросы медицинской химии. 1995. Т. 41, № 1. С. 53–57.
27. Коденцова В.М., Вржесинская О.А., Спиричев В.Б. Изменение обеспеченности витаминами взрослого населения Российской Федерации за период 1987–2009 гг. (к 40-летию лаборатории витаминов и минеральных веществ НИИ питания РАМН) // Вопросы питания. 2010. Т. 79, № 3. P. 68–72.
28. Gey K.F. Vitamins E plus C and interacting conutrients required for optimal health // Biofactors. 1998. Vol. 7, N 1–2. P. 143–174. DOI: https://doi.org/10.1002/biof.5520070115
29. Спиричев В.Б., Коденцова В.М., Вржесинская О.А., Бекетова Н.А., Харитончик Л.А., Алексеева И.А. и др. Методы оценки витаминной обеспеченности населения // Учебно-методическое пособие. Москва : Альтекс, 2001. 68 с.
30. Horwitt M.K., Harvey C.C., Dahm C.H., Searcy M.T. Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy // Ann. N. Y. Acad. Sci. 1972. Vol. 203. P. 223–235. DOI: https://doi.org/10.1111/j.1749-6632.1972.tb27878.x
31. Вржесинская О.А., Бекетова Н.А., Кошелева О.В., Коденцова В.М., Шарафетдинов Х.Х. Оценка витаминного статуса пациентов с морбидным ожирением по совокупности признаков оптимальной обеспеченности // Медицинский вестник Северного Кавказа. 2020. Т. 15, № 4. С. 504–509. DOI: https://doi.org/10.14300/mnnc.2020.15118
32. Liyanage P.L.G.C., Lekamwasam S., Weerarathna T.P., Liyanage C. Effect of vitamin D therapy on urinary albumin excretion, renal functions, and plasma renin among patients with diabetic nephropathy: a randomized, double-blind clinical trial // J. Postgrad. Med. 2018. Vol. 64, N 1. P. 10–15. DOI: https://doi.org/10.4103/jpgm.JPGM_ 598_16
33. Zhang Q., Zhang M., Wang H., Sun C., Feng Y., Zhu W. et al. Vitamin D supplementation improves endothelial dysfunction in patients with non-dialysis chronic kidney disease // Int. Urol. Nephrol. 2018. Vol. 50, N 5. P. 923–927. DOI: https://doi.org/10.1007/s11255-018-1829-6
34. Lundwall K., Jacobson S.H., Jörneskog G., Spaak J. Treating endothelial dysfunction with vitamin D in chronic kidney disease: a meta-analysis // BMC Nephrol. 2018. Vol. 19. P. 247. DOI: https://doi.org/10.1186/s12882-018-1042-y
35. Tan G.C.J., Tan S.M.Q., Phang S.C.W., Ng Y.T., Ng E.Y., Ahmad B. et al. Tocotrienol-rich vitamin E improves diabetic nephropathy and persists 6–9 months after washout: a phase IIa randomized controlled trial // Ther. Adv. Endocrinol. Metab. 2019. Vol. 10. Article ID 2042018819895462. DOI: https://doi.org/10.1177/2042018819895462
36. Koay Y.Y., Tan G.C.J., Phang S.C.W., Ho J.I., Chuar P.F., Ho L.S. et al. A phase IIb randomized controlled trial investigating the effects of tocotrienol-rich vitamin E on diabetic kidney disease // Nutrients. 2021. Vol. 13, N 1. P. 258. DOI: https://doi.org/10.3390/nu13010258
37. Szewczyk K., Chojnacka A., Górnicka M. Tocopherols and tocotrienols – bioactive dietary compounds; what is certain, what is doubt? // Int. J. Mol. Sci. 2021. Vol. 22, N 12. P. 6222. DOI: https://doi.org/10.3390/ijms22126222
38. Farvid M.S., Jalali M, Siassi, F. Hosseini M. Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes // Diabetes Care. 2005. Vol. 28, N 10. P. 2458–2464. DOI: https://doi.org/10.2337/diacare.28.10.2458
39. Коденцова В.М., Рисник Д.В. Микронутриентные метаболические сети и множественный дефицит микронутриентов: обоснование преимуществ витаминно-минеральных комплексов // Микроэлементы в медицине. 2020. Т. 21, № 4. С. 3−20. DOI: https://doi.org/10.19112/2413-6174-2020-21-4-3-20
References
1. Podkowińska A., Formanowicz D. Chronic kidney disease as oxidative stress-and inflammatory-mediated cardiovascular disease. Antioxidants (Basel). 2020; 9 (8): 752. DOI: https://doi.org/10.3390/antiox9080752
2. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020; 395: 709–33. DOI: https://doi.org/10.1016/S0140-6736(20)30045-3
3. Tinti F., Lai S., Noce A., Rotondi S., Marrone G., Mazzaferro S., et al. Chronic kidney disease as a systemic inflammatory syndrome: update on mechanisms involved and potential treatment. Life (Basel). 2021; 11 (5): 419. DOI: https://doi.org/10.3390/life11050419
4. Wang G., Ouyang J., Li S., Wang H., Lian B., Liu Z., et al. The analysis of risk factors for diabetic nephropathy progression and the construction of a prognostic database for chronic kidney diseases. J Transl Med. 2019; 17: 264. DOI: https://doi.org/10.1186/s12967-019-2016-y
5. Jankowska M., Rutkowski B., Dębska-Ślizień A. Vitamins and microelement bioavailability in different stages of chronic kidney disease. Nutrients. 2017; 9 (3): 282. DOI: https://doi.org/10.3390/nu9030282
6. van de Wal-Visscher E.R., Kooman J.P., van der Sande F.M. Magnesium in chronic kidney disease: should we care? Blood Purif. 2018; 45 (1–3): 173–8. DOI: https://doi.org/10.1159/000485212
7. Van Kempen T.A., Deixler E. SARS-CoV-2: influence of phosphate and magnesium, moderated by vitamin D, on energy (ATP) metabolism and on severity of COVID-19. Am J Physiol Endocrinol Metab. 2021; 320 (1): E2–6. DOI: https://doi.org/10.1152/ajpendo.00474.2020
8. Tanaka K., Ao M., Kuwabara A. Insufficiency of B vitamins with its possible clinical implications. J Clin Biochem Nutr. 2020; 67 (1): 19–25. DOI: https://doi.org/10.3164/jcbn.20-56
9. Adaikalakoteswari A.A., Rabbani N.A., Waspadji S.B., Tjokroprawiro A.C., Kariadi S.H.K.S., Adam J.M.F.E., et al. Disturbance of B-vitamin status in people with type 2 diabetes in Indonesia – link to renal status, glycemic control and vascular inflammation. Diabetes Res Clin Pract. 2012; 95 (3): 415–24. DOI: https://doi.org/10.1016/j.diabres.2011.10.042
10. Iwakawa H., Nakamura Y., Fukui T., Fukuwatar T., Ugi S., Maegawa H., et al. Concentrations of water-soluble vitamins in blood and urinary excretion in patients with diabetes mellitus. Nutr Metab Insights. 2016; 9: 85–92. DOI: https://doi.org/10.4137/NMI.S40595
11. Anwar A., Azmi M.A., Siddiqui J.A., Panhwar G., Shaikh F., Ariff M. Thiamine level in type I and type II diabetes mellitus patients: a comparative study focusing on hematological and biochemical evaluations. Cureus. 2020; 12 (5): e8027. DOI: https://doi.org/10.7759/cureus.8027
12. Nix W.A., Zirwes R., Bangert V., Kaiser R.P., Schilling M., Hostalek U., et al. Vitamin B status in patients with type 2 diabetes mellitus with and without incipient nephropathy. Diabetes Res Clin Pract. 2015; 107 (1): 157–65. DOI: https://doi.org/10.1016/j.diabres.2014.09.058
13. Valdés-Ramos R., Guadarrama-López A.L., Martínez-Carrillo B.E., Benítez-Arciniega A.D. Vitamins and type 2 diabetes mellitus. Endocr Metab Immune Disord Drug Targets. 2015; 15 (1): 54–63. DOI: https://doi.org/10.2174/1871530314666141111103217
14. Gavrilov V., Harman-Boehm I., Amichay D., Tessler G., Shuster T., Friger M., et al. Kidney function and retinol status in type 2 diabetes mellitus patients. Acta Diabetol. 2012; 49 (2): 137–43. DOI: https://doi.org/10.1007/s00592-011-0303-z
15. Novikova M.S., Rudenko T.E., Kotyashkova O.M., Antsiferov M.B. Mineral and bone disorders in patients with diabetes mellitus and chronic kidney disease. Effektivnaya farmakoterapiya [Effective Pharmacotherapy]. 2013. (46): 46–52. (in Russian)